Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
JMIR Research Protocols|August 11, 2020
An Employment Intervention Program (Work2Prevent) for Young Men Who Have Sex With Men and Transgender Youth of Color (Phase 2): Protocol for a Single-Arm Mixed Methods Pilot Test to Assess Feasibility and AcceptabilityBrandon J Hill, Darnell N Motley, Kris Rosentel, et al.
JMIR Research Protocols|March 19, 2019
Triggered Escalating Real-Time Adherence Intervention to Promote Rapid HIV Viral Suppression Among Youth Living With HIV Failing Antiretroviral Therapy: Protocol for a Triggered Escalating Real-Time Adherence InterventionK Rivet Amico, Amanda Dunlap, Ronald Dallas, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|March 20, 2022
Lower Risk of Recurrence with a Higher Induction Dose of Mesalazine and Longer Duration of Treatment in Ulcerative Colitis: Results from the Dutch, Non-Interventional, IMPACT StudyRachel West, Maurice Russel, Alexander Bodelier, et al.
BMC Pulmonary Medicine|April 4, 2019
Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in childrenMejbah U Bhuiyan, Christopher C Blyth, Rachel West, et al.
Thorax|October 20, 2018
The contribution of viruses and bacteria to community-acquired pneumonia in vaccinated children: a case-control studyMejbah Uddin Bhuiyan, Thomas L Snelling, Rachel West, et al.
Journal of Clinical Medicine|September 14, 2024
Clinical Trial: A Pragmatic Randomised Controlled Study to Assess the Effectiveness of Two Patient Management Strategies in Mild to Moderate Ulcerative Colitis-The OPTIMISE StudySilvio Danese, Gionata Fiorino, Eric Vicaut, et al.
The Lancet. Gastroenterology & Hepatology|November 21, 2024
Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trialGeert D'Haens, Carlos Taxonera, Antonio Lopez-Sanroman, et al.
European Journal of Gastroenterology & Hepatology|December 5, 2022
Retreatment with anti-tumor necrosis factor therapy in combination with an immunomodulator for recurrence of Crohn's disease after ileocecal resection results in prolonged continuation as compared to anti-tumor necrosis factor monotherapySebastiaan Ten Bokkel Huinink, Evelien M J Beelen, Thomas Ten Bokkel Huinink, et al.
BJS Open|September 29, 2023
Impact of timing of primary ileocecal resection on prognosis in patients with Crohn's diseaseEvelien M J Beelen, Jeanine H C Arkenbosch, Nicole S Erler, et al.
International Journal of Colorectal Disease|October 19, 2023
Preoperative screening and prehabilitation strategies prior to ileocolic resection in patients with Crohn's disease are not incorporated in routine careMichiel Thomas Jan Bak, Oddeke van Ruler, Laurents Stassen, et al.
Pageof 4